| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.71▼ | 2.73▼ | 2.72▼ | 2.60▲ | 2.44▲ |
| MA10 | 2.71▼ | 2.73▼ | 2.66▲ | 2.47▲ | 2.62▲ |
| MA20 | 2.72▼ | 2.66▲ | 2.63▲ | 2.40▲ | 2.29▲ |
| MA50 | 2.73▼ | 2.62▲ | 2.51▲ | 2.61▲ | 1.57▲ |
| MA100 | 2.67▲ | 2.49▲ | 2.45▲ | 2.24▲ | 1.25▲ |
| MA200 | 2.63▲ | 2.44▲ | 2.39▲ | 1.70▲ | 3.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.001▲ | 0.006▲ | 0.046▲ | -0.038▼ |
| RSI | 41.903▼ | 58.156▲ | 61.661▲ | 58.659▲ | 60.684▲ |
| STOCH | 47.540 | 64.269 | 88.957▲ | 76.310 | 26.868 |
| WILL %R | -75.000 | -17.910▲ | -17.910▲ | -10.526▲ | -46.354 |
| CCI | -99.454 | 18.742 | 65.393 | 128.915▲ | 21.867 |
|
Wednesday, November 12, 2025 09:52 AM
Detailed price information for Gossamer Bio Inc (GOSS-Q) from The Globe and Mail including charting and trades.
|
|
Friday, November 07, 2025 01:30 PM
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...
|
|
Wednesday, November 05, 2025 12:01 PM
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 2.42 | 2.77 | 2.42 | 2.71 | 2,785,582 |
| 13/11/25 | 2.65 | 2.6615 | 2.50 | 2.51 | 2,324,557 |
| 12/11/25 | 2.63 | 2.71 | 2.535 | 2.70 | 3,419,273 |
| 11/11/25 | 2.49 | 2.595 | 2.46 | 2.59 | 2,300,251 |
| 10/11/25 | 2.45 | 2.6199 | 2.44 | 2.48 | 4,073,072 |
| 07/11/25 | 2.30 | 2.41 | 2.205 | 2.36 | 2,091,629 |
| 06/11/25 | 2.282 | 2.41 | 2.28 | 2.31 | 2,346,750 |
| 05/11/25 | 2.29 | 2.375 | 2.20 | 2.37 | 2,292,266 |
| 04/11/25 | 2.35 | 2.37 | 2.28 | 2.30 | 1,937,214 |
| 03/11/25 | 2.49 | 2.49 | 2.35 | 2.39 | 2,493,831 |
|
|
||||
|
|
||||
|
|